Germany supplies 72.8% of U.S. imports of Insulin-Containing Medicaments in Dosage Form, across 7 countries (year to date through September 2026).
HHI 5,800 of 10,000 · HHI above 1,800. The sum of each country’s squared percentage share; one country with everything scores 10,000.
7 countries supplying this product to the U.S.
| Rank# | Country | Value | Share | YoY | Duty |
|---|---|---|---|---|---|
| 1 | Germany | $71.6M | 80.9% | +24.1% | 0.0% |
| 2 | Malaysia | $11.7M | 13.3% | +15.7% | 0.0% |
| 3 | China | $2.9M | 3.3% | -- | 0.0% |
| 4 | Denmark | $1.5M | 1.7% | -44.7% | 0.0% |
| 5 | France | $665K | 0.8% | -51.4% | 15.0% |
| 6 | India | -- | 0.0% | -- | -- |
| 7 | Zimbabwe | -- | 0.0% | -- | -- |
Duty is the duty Census calculated on this month's imports for consumption from each country, as a share of their customs value. It applies the rates in force, additional duties such as Section 301, 232 and IEEPA included and claimed trade-agreement preferences netted out, so it is an observed rate rather than a statutory one. It is an estimate, not duty collected: antidumping and countervailing duties, fees and later refunds are not in it. YoY compares year-to-date value with the same months last year.